188 related articles for article (PubMed ID: 33218035)
21. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
22. An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.
Bird RC; Deinnocentes P; Church Bird AE; van Ginkel FW; Lindquist J; Smith BF
Cancer Immunol Immunother; 2011 Jan; 60(1):87-97. PubMed ID: 21069323
[TBL] [Abstract][Full Text] [Related]
23. Somatic Mutation of
Lee KH; Hwang HJ; Noh HJ; Shin TJ; Cho JY
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31842489
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation patterns in the Fhit regulatory region are tissue specific.
Guler G; Iliopoulos D; Han SY; Fong LY; Lubet RA; Grubbs CJ; Huebner K
Mol Carcinog; 2005 Jul; 43(3):175-81. PubMed ID: 15937960
[TBL] [Abstract][Full Text] [Related]
25. Over-expression of mammaglobin-B in canine mammary tumors.
Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
[TBL] [Abstract][Full Text] [Related]
26. Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.
Haldrup C; Pedersen AL; Øgaard N; Strand SH; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Mol Oncol; 2018 Apr; 12(4):545-560. PubMed ID: 29465788
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq).
Liu X; Ren J; Luo N; Guo H; Zheng Y; Li J; Tang F; Wen L; Peng J
Clin Epigenetics; 2019 Jun; 11(1):93. PubMed ID: 31234922
[TBL] [Abstract][Full Text] [Related]
29. Methylation analysis of plasma cell-free DNA for breast cancer early detection using bisulfite next-generation sequencing.
Li Z; Guo X; Tang L; Peng L; Chen M; Luo X; Wang S; Xiao Z; Deng Z; Dai L; Xia K; Wang J
Tumour Biol; 2016 Oct; 37(10):13111-13119. PubMed ID: 27449045
[TBL] [Abstract][Full Text] [Related]
30. Identification of EDIL3 biomarkers as a biomarker and potential therapeutic target of canine mammary carcinomas based on integrated bioinformatics analysis.
Lin Z; Jiang C; Lv D; Lin D
Vet Immunol Immunopathol; 2022 Jul; 249():110432. PubMed ID: 35550248
[TBL] [Abstract][Full Text] [Related]
31. Of humans and canines: a comparative evaluation of heat shock and apoptosis-associated proteins in mammary tumors.
Kumaraguruparan R; Karunagaran D; Balachandran C; Manohar BM; Nagini S
Clin Chim Acta; 2006 Mar; 365(1-2):168-76. PubMed ID: 16176813
[TBL] [Abstract][Full Text] [Related]
32. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis.
Faryna M; Konermann C; Aulmann S; Bermejo JL; Brugger M; Diederichs S; Rom J; Weichenhan D; Claus R; Rehli M; Schirmacher P; Sinn HP; Plass C; Gerhauser C
FASEB J; 2012 Dec; 26(12):4937-50. PubMed ID: 22930747
[TBL] [Abstract][Full Text] [Related]
35. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
[TBL] [Abstract][Full Text] [Related]
36. Cancer Detection and Classification by CpG Island Hypermethylation Signatures in Plasma Cell-Free DNA.
Huang J; Soupir AC; Schlick BD; Teng M; Sahin IH; Permuth JB; Siegel EM; Manley BJ; Pellini B; Wang L
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830765
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone induces tyrosyl phosphorylation of the transcription factors Stat5a and Stat5b in CMT-U335 canine mammary tumor cells.
van Garderen E; Swennenhuis JF; Hellmén E; Schalken JA
Domest Anim Endocrinol; 2001 Feb; 20(2):123-35. PubMed ID: 11311850
[TBL] [Abstract][Full Text] [Related]
39. Methylation of NBPF1 as a novel marker for the detection of plasma cell-free DNA of breast cancer patients.
Li D; Li P; Wu J; Yi J; Dou Y; Guo X; Yin Y; Wang D; Ma C; Qiu L
Clin Chim Acta; 2018 Sep; 484():81-86. PubMed ID: 29775621
[TBL] [Abstract][Full Text] [Related]
40. Comparative epigenomics of human and mouse mammary tumors.
Demircan B; Dyer LM; Gerace M; Lobenhofer EK; Robertson KD; Brown KD
Genes Chromosomes Cancer; 2009 Jan; 48(1):83-97. PubMed ID: 18836996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
